IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomasAdriana Olar, Kenneth Aldape|Acta Neuropathologica|2015Cited by 350
Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemicNimish Mohile, Mateo Ziu, Na Tosha Gatson et al.|Neuro-Oncology|2020Cited by 79
A gene expression signature predicts recurrence-free survival in meningiomaAdriana Olar, Erik P. Sulman|Oncotarget|2018Cited by 31
Phosphohistone H3: implications for clinical practice and risk assessment in meningiomaAdriana Olar|Neuro-Oncology|2015Cited by 9